Rachel Qualley, MD
Dermatology · Wildwood, MONPI 1518078567
Payments from drug & device makers
Across 194 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$580
- Johnson & Johnson$368
- Dermavant Sciences, Inc.$331
- Amgen$295
- Novartis$242
- E.r. Squibb & Sons, L.L.C.$232
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,08992%
- Education$2698%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $580 |
| Johnson & Johnson | 11 | $368 |
| Dermavant Sciences, Inc. | 32 | $331 |
| Amgen | 14 | $295 |
| Novartis | 10 | $242 |
| E.r. Squibb & Sons, L.L.C. | 18 | $232 |
| UCB, Inc. | 7 | $180 |
| Lilly USA, LLC | 8 | $150 |
| Sun Pharmaceutical Industries Inc. | 6 | $102 |
| Sanofi | 3 | $82 |
| EPI Health, LLC | 4 | $66 |
| Arcutis Biotherapeutics, Inc. | 4 | $65 |
| Bristol Myers Squibb | 1 | $65 |
| Pfizer | 4 | $62 |
| Galderma Laboratories, L.p. | 4 | $57 |
| Botanix SB Inc | 3 | $55 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| Organon | 9 | $48 |
| Krystal Biotech Inc | 2 | $41 |
| LEO Pharma Inc. | 2 | $38 |
| Mallinckrodt Hospital Products Inc. | 1 | $37 |
| Mission Pharmacal Company | 2 | $37 |
| Mayne Pharma Commercial LLC | 3 | $34 |
| Boehringer Ingelheim | 1 | $26 |
| Biofrontera Inc. | 2 | $25 |
| Incyte Corporation | 1 | $22 |
| Journey Medical Corporation | 1 | $16 |
How this compares
$3,358 in reported general payments places this provider in the 45th percentile of 263 dermatology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 25 | $2,058 |
| Metronidazole | 38 | $1,947 |
| Ketoconazole | 116 | $1,555 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 49 | $1,445 |
| Clindamycin Phosphate | 36 | $984 |
| Fluocinonide | 21 | $762 |
| Clobetasol Propionate | 23 | $624 |
| Doxycycline Hyclate | 21 | $315 |
| Triamcinolone Acetonide | 42 | $205 |
| Spironolactone | 12 | $186 |
| Minoxidil | 17 | $146 |
| Mupirocin | 15 | $70 |
| Terbinafine Hcl | 11 | $66 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Wildwood
- Christopher KlingWildwood$139K
- Melody StoneSaint Joseph$4.3M
- Milan AnadkatSaint Louis$2.4M
- Brian KimSaint Louis$2.3M
- Elaine SiegfriedSaint Louis$2.2M
- Craig LeonardiSaint Louis$1.7M
- David CleaverKirksville$789K
- Amy MusiekSaint Louis$577K
- Ann MartinSaint Louis$512K
- Jonathan CleaverKirksville$483K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.